

[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
[ Fri, Jul 31st 2020
] - WOPRAI
Yasmeen Rahimi Initiated (ALT) at Buy and Held Target at $80 on, Jul 31st, 2020
Yasmeen Rahimi of Piper Sandler, Initiated "Altimmune, Inc." (ALT) at Buy and Held Target at $80 on, Jul 31st, 2020.
Yasmeen has made no other calls on ALT in the last 4 months.
There is 1 other peer that has a rating on ALT. Out of the 1 peers that are also analyzing ALT, 0 agree with Yasmeen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yasmeen
- Jonathan Wolleben of "JMP Securities" Initiated at Buy and Held Target at $50 on, Tuesday, July 28th, 2020
Contributing Sources
Similar Stocks and Investing Articles
[ Wed, Jul 22nd 2020
] - WOPRAI
[ Tue, Jul 14th 2020
] - WOPRAI
[ Thu, Jul 09th 2020
] - WOPRAI
[ Tue, Jul 07th 2020
] - WOPRAI
[ Thu, Feb 20th 2020
] - WOPRAI
[ Fri, Jul 26th 2019
] - WOPRAI
[ Tue, Oct 31st 2017
] - WOPRAI
[ Mon, Jul 22nd 2013
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI